echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > 【Scientific Research News】College of Life Science and Technology/National Center for Nanoengineering-Professor Yang Xiangliang and Associate Professor Zhang Yan's team in protein...

    【Scientific Research News】College of Life Science and Technology/National Center for Nanoengineering-Professor Yang Xiangliang and Associate Professor Zhang Yan's team in protein...

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Professor Yang Xiangliang and Associate Professor Zhang Yan from the School of Life Science and Technology, Huazhong University of Science and Technology have made new progress
    in protease-activated nanozymes for photoacoustic/magnetic resonance-guided combination therapy of tumor ferrozois-photothermal therapy 。 The related research results were published in Advanced Functional in a research paper entitled "Protease-Activatable Nanozyme with Photoacoustic and Tumor-Enhanced Magnetic Resonance Imaging for Photothermal Ferroptosis Cancer Therapy" Materials

    Ferroptosis is a programmed death modality
    of iron-dependent cells.
    The main mechanism of ferrozois is the production of excess hydroxyl radicals (· OH), catalyzes the highly expressed
    unsaturated fatty acids on the cell membrane, and lipid peroxidation occurs, thereby inducing cellular iron death; It is also manifested by depletion of glutathione and decreased
    glutathione peroxidase (GPX4) activity.
    The development of highly effective iron-dead induction drugs is one of the effective ways of
    anti-tumor treatment.
    However, at present, iron-dead induction drugs have shortcomings such as high systemic distribution of drugs after systematic administration, high toxicity, and limited tumor cell killing effect
    .
    In view of the above problems, the research team chose to use gelatin as a template
    , prepared Fe3O4 nanoclusters by metal coordination, combined with defective Cu1.
    77Se, and developed metalloproteinase-activated Fe3O4@Cu1.
    77Se nanoenzymes
    .

    Compared with other nanozymes, the nanozyme can maintain stable structure and performance in the physiological environment; In the presence of matrix metalloproteinases, Fe3O4@Cu1.
    77Se can rapidly depolymerize, releasing ultranumerous, ultra-small Fe3O4 and Cu1.
    77Se nanoparticles, which not only causes nanozyme NMR T2 signal enhancement, but also improves the efficiency of the (quasi)Fenton reaction of Fe3O4@Cu1.
    77Se and enhances its hydroxyl radicals (· OH) Generation and GSH consumption efficiency
    .
    At the same time, Cu1.
    77Se has good photothermal conversion efficiency in the near-infrared II region, which can not only produce good photothermal effects when irradiated at 1064 nm, but also further enhance the nanoenzyme Fenton reaction and GSH consumption efficiency, and achieve the synergistic effect
    of 1+1>2.

    After intravenous administration, under the guidance of an exogenous magnetic field, Fe3O4@Cu1.
    77Se nanoenzyme can be efficiently enriched
    in tumor tissue.
    In tumor tissues rich in matrix metalloproteinases and exogenous 1064 nm light sources, Fe3O4@Cu1.
    77Se nanoenzymes can not only effectively
    enhance the lipid peroxidation of tumor cell membranes, significantly enhance the process of iron death in tumor cells, but also produce photothermal effects to achieve the synergistic anti-tumor therapeutic effect
    of 1+1>2 。 The treatment process effectively induces the immunogenic death of tumor cells, activates dendritic cell maturation, leads to the infiltration of toxic T lymphocytes, and causes reverse polarization of tumor-associated macrophages, thereby activating the immune response and effectively inhibiting the growth of proximal and distal tumors and lung metastasis
    of tumors.

    This work provides an idea for the design of tumor in situ activated hemozotic nanodrugs, and realizes synergistic and efficient anti-tumor treatment
    by effectively avoiding the potential harm caused by the off-target effect of iron-dead induction drugs in the non-tumor microenvironment.

    Figure 1.
    Construction of protease-activated nanoenzyme
    Fe3O4@Cu 1.
    77
    Se, evaluation of therapeutic effect and mechanism


    Qin Wen and Huang Zhao, doctoral students in the School of Life Science and Technology, are the co-first authors of the paper, and Associate Professor Zhang Yan, School of Life Science and Technology, Huazhong University of Science and Technology, is the corresponding author
    of the paper.
    This work was supported
    by the National Key Research and Development Program of China (2021YFA1201200).


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.